Beryl Drugs Ltd. engages in the manufacture of bulk drugs. The company is headquartered in Indore, Madhya Pradesh. The firm is principally engaged in the manufacturing of bulk drugs. The firm offers a range of manufacturing options to its product requirements, including small volume injectable in liquid form; small volume injectable in dry powder form; a range of eye and ear drops; intravenous (I.V.) fluids in the poly pack and glass bottles, and a range of veterinary medicines. The firm's manufacturing facility is located in Pithampur, India. The firm is mainly engaged in domestic, institutional and export supply. The firm markets a range of branded, generic pharmaceutical formulations through its nationwide sales and distribution network.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.